These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32618247)

  • 1. Impact of Four Rounds of Mass Drug Administration with Dihydroartemisinin-Piperaquine Implemented in Southern Province, Zambia.
    Eisele TP; Bennett A; Silumbe K; Finn TP; Porter TR; Chalwe V; Hamainza B; Moonga H; Kooma E; Chizema Kawesha E; Kamuliwo M; Yukich JO; Keating J; Schneider K; Conner RO; Earle D; Slutsker L; Steketee RW; Miller JM
    Am J Trop Med Hyg; 2020 Aug; 103(2_Suppl):7-18. PubMed ID: 32618247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to Mass Drug Administration with Dihydroartemisinin-Piperaquine and
    Finn TP; Porter TR; Moonga H; Silumbe K; Daniels RF; Volkman SK; Yukich JO; Keating J; Bennett A; Steketee RW; Miller JM; Eisele TP
    Am J Trop Med Hyg; 2020 Aug; 103(2_Suppl):37-45. PubMed ID: 32618267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-Effectiveness of Focal Mass Drug Administration and Mass Drug Administration with Dihydroartemisinin-Piperaquine for Malaria Prevention in Southern Province, Zambia: Results of a Community-Randomized Controlled Trial.
    Yukich JO; Scott C; Silumbe K; Larson BA; Bennett A; Finn TP; Hamainza B; Conner RO; Porter TR; Keating J; Steketee RW; Eisele TP; Miller JM
    Am J Trop Med Hyg; 2020 Aug; 103(2_Suppl):46-53. PubMed ID: 32618249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment Coverage Estimation for Mass Drug Administration for Malaria with Dihydroartemisinin-Piperaquine in Southern Province, Zambia.
    Finn TP; Yukich JO; Bennett A; Porter TR; Lungu C; Hamainza B; Chizema Kawesha E; Conner RO; Silumbe K; Steketee RW; Miller JM; Keating J; Eisele TP
    Am J Trop Med Hyg; 2020 Aug; 103(2_Suppl):19-27. PubMed ID: 32618251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moving from Malaria Burden Reduction toward Elimination: An Evaluation of Mass Drug Administration in Southern Province, Zambia.
    Miller JM; Eisele TP; Fraser MS; Lewis MT; Slutsker L; Chizema Kawesha E
    Am J Trop Med Hyg; 2020 Aug; 103(2_Suppl):3-6. PubMed ID: 32618265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term Impact of Mass Drug Administration With Dihydroartemisinin Plus Piperaquine on Malaria in Southern Province Zambia: A Cluster-Randomized Controlled Trial.
    Eisele TP; Bennett A; Silumbe K; Finn TP; Chalwe V; Kamuliwo M; Hamainza B; Moonga H; Kooma E; Chizema Kawesha E; Yukich J; Keating J; Porter T; Conner RO; Earle D; Steketee RW; Miller JM
    J Infect Dis; 2016 Dec; 214(12):1831-1839. PubMed ID: 27923947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of the MDA Trial in Southern Province, Zambia, for Malaria Control and Elimination.
    Steketee RW; Miller JM; Chizema Kawesha E
    Am J Trop Med Hyg; 2020 Aug; 103(2_Suppl):98-101. PubMed ID: 32618248
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessing the effectiveness of household-level focal mass drug administration and community-wide mass drug administration for reducing malaria parasite infection prevalence and incidence in Southern Province, Zambia: study protocol for a community randomized controlled trial.
    Eisele TP; Silumbe K; Finn T; Chalwe V; Kamuliwo M; Hamainza B; Moonga H; Bennett A; Yukich J; Keating J; Steketee RW; Miller JM
    Trials; 2015 Aug; 16():347. PubMed ID: 26268804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Longitudinal Cohort to Monitor Malaria Infection Incidence during Mass Drug Administration in Southern Province, Zambia.
    Bennett A; Porter TR; Mwenda MC; Yukich JO; Finn TP; Lungu C; Silumbe K; Mambwe B; Chishimba S; Mulube C; Bridges DJ; Hamainza B; Slutsker L; Steketee RW; Miller JM; Eisele TP
    Am J Trop Med Hyg; 2020 Aug; 103(2_Suppl):54-65. PubMed ID: 32618245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community-led Responses for Elimination (CoRE): a study protocol for a community randomized controlled trial assessing the effectiveness of community-level, reactive focal drug administration for reducing Plasmodium falciparum infection prevalence and incidence in Southern Province, Zambia.
    Bridges DJ; Miller JM; Chalwe V; Moonga H; Hamainza B; Steketee R; Silumbe K; Nyangu J; Larsen DA
    Trials; 2017 Nov; 18(1):511. PubMed ID: 29096671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass drug administration for the acceleration of malaria elimination in a region of Myanmar with artemisinin-resistant falciparum malaria: a cluster-randomised trial.
    McLean ARD; Indrasuta C; Khant ZS; Phyo AK; Maung SM; Heaton J; Aung H; Aung Y; Soe K; Swe MMM; von Seidlein L; Tun NN; Tun KM; Day NPJ; Ashley EA; Hlaing T; Kyaw TT; Dondorp AM; Imwong M; White NJ; Smithuis FM
    Lancet Infect Dis; 2021 Nov; 21(11):1579-1589. PubMed ID: 34147154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of
    Chishimba S; Mwenda M; Mambwe B; Mulube C; Chalwe V; Moonga H; Hamainza B; Chizema-Kawesha E; Steketee RW; Domingo G; Fraser M; Kahn M; Pal S; Silumbe K; Conner RO; Bennett A; Porter TR; Eisele TP; Miller JM; Bridges DJ
    Am J Trop Med Hyg; 2020 Aug; 103(2_Suppl):82-89. PubMed ID: 32618252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the Acceptability of Testing and Treatment during a Mass Drug Administration Trial for Malaria in Zambia Using Mixed Methods.
    Silumbe K; Finn TP; Jennings T; Sikombe C; Chiyende E; Hamainza B; Chizema Kawesha E; Eisele TP; Earle D; Steketee RW; Miller JM
    Am J Trop Med Hyg; 2020 Aug; 103(2_Suppl):28-36. PubMed ID: 32618242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Controlled Trial of Mass Drug Administration to Interrupt Transmission of Multidrug-Resistant Falciparum Malaria in Cambodian Villages.
    Tripura R; Peto TJ; Chea N; Chan D; Mukaka M; Sirithiranont P; Dhorda M; Promnarate C; Imwong M; von Seidlein L; Duanguppama J; Patumrat K; Huy R; Grobusch MP; Day NPJ; White NJ; Dondorp AM
    Clin Infect Dis; 2018 Aug; 67(6):817-826. PubMed ID: 29522113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cluster randomised controlled trial of two rounds of mass drug administration in Zanzibar, a malaria pre-elimination setting-high coverage and safety, but no significant impact on transmission.
    Morris U; Msellem MI; Mkali H; Islam A; Aydin-Schmidt B; Jovel I; Shija SJ; Khamis M; Ali SM; Hodzic L; Magnusson E; Poirot E; Bennett A; Sachs MC; Tarning J; Mårtensson A; Ali AS; Björkman A
    BMC Med; 2018 Dec; 16(1):215. PubMed ID: 30526588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dynamic of asymptomatic Plasmodium falciparum infections following mass drug administrations with dihydroarteminisin-piperaquine plus a single low dose of primaquine in Savannakhet Province, Laos.
    Pongvongsa T; Phommasone K; Adhikari B; Henriques G; Chotivanich K; Hanboonkunupakarn B; Mukaka M; Peerawaranun P; von Seidlein L; Day NPJ; White NJ; Dondorp AM; Imwong M; Newton PN; Singhasivanon P; Mayxay M; Pukrittayakamee S
    Malar J; 2018 Nov; 17(1):405. PubMed ID: 30390647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Travel History and
    Porter TR; Finn TP; Silumbe K; Chalwe V; Hamainza B; Kooma E; Moonga H; Bennett A; Yukich JO; Steketee RW; Keating J; Miller JM; Eisele TP
    Am J Trop Med Hyg; 2020 Aug; 103(2_Suppl):74-81. PubMed ID: 32618250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: A cluster randomised trial.
    von Seidlein L; Peto TJ; Landier J; Nguyen TN; Tripura R; Phommasone K; Pongvongsa T; Lwin KM; Keereecharoen L; Kajeechiwa L; Thwin MM; Parker DM; Wiladphaingern J; Nosten S; Proux S; Corbel V; Tuong-Vy N; Phuc-Nhi TL; Son DH; Huong-Thu PN; Tuyen NTK; Tien NT; Dong LT; Hue DV; Quang HH; Nguon C; Davoeung C; Rekol H; Adhikari B; Henriques G; Phongmany P; Suangkanarat P; Jeeyapant A; Vihokhern B; van der Pluijm RW; Lubell Y; White LJ; Aguas R; Promnarate C; Sirithiranont P; Malleret B; Rénia L; Onsjö C; Chan XH; Chalk J; Miotto O; Patumrat K; Chotivanich K; Hanboonkunupakarn B; Jittmala P; Kaehler N; Cheah PY; Pell C; Dhorda M; Imwong M; Snounou G; Mukaka M; Peerawaranun P; Lee SJ; Simpson JA; Pukrittayakamee S; Singhasivanon P; Grobusch MP; Cobelens F; Smithuis F; Newton PN; Thwaites GE; Day NPJ; Mayxay M; Hien TT; Nosten FH; Dondorp AM; White NJ
    PLoS Med; 2019 Feb; 16(2):e1002745. PubMed ID: 30768615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination.
    Gerardin J; Eckhoff P; Wenger EA
    BMC Infect Dis; 2015 Mar; 15():144. PubMed ID: 25887935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass Drug Administration With Dihydroartemisinin-piperaquine and Malaria Transmission Dynamics in The Gambia: A Prospective Cohort Study.
    Mwesigwa J; Achan J; Affara M; Wathuo M; Worwui A; Mohammed NI; Kanuteh F; Prom A; Dierickx S; di Tanna GL; Nwakanma D; Bousema T; Drakeley C; Van Geertruyden JP; D'Alessandro U
    Clin Infect Dis; 2019 Jul; 69(2):278-286. PubMed ID: 30304511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.